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Two interesting studies on the brain-heart connection were
recently presented. At the 12th Annual Spring Meeting on
Cardiovascular Nursing of the European Society of Car-
diology (ESC) in Copenhagen, Denmark (16/17 March,
2012), Nikki Damen, a PhD student at Tilburg University,
reported that patients who are depressed after coronary artery
stenting have a worse prognosis. The authors reported
that in patients with coronary stents depression was
associated with a 1.5 times greater risk of death during
a seven-year study period. The study included 1234 coronary
arterydisease patientsinthe Netherlands (mean age 62years),
who underwent assessment for depression six months
after receiving a coronary stent. Depression was diag-
nosed in 324 (26 %) of the patients. After seven years
follow-up, 187 of the patients had died, of whom 23 %
of the patients with depression and 12 % of the patients
without depression. The researchers found that gender
and age were factors in the increased risk, with men
and older patients significantly more likely to die during
the study. However, the use of cholesterol-lowering sta-
tins was associated with a reduced risk of death among study
participants. The intriguing Tilburg study awaits further
publication.
One possible reason for the increased risk of earlier
death is that depressed patients may have less healthy
lifestyles in terms of smoking, drinking alcohol, exercise
and diet. It could also be that depression alters the
activity of the sympathetic nervous system, resulting in
increased blood pressure and heart rate. Finally it was
proposed that these patients may also be less likely to
take their medication. The authors therefore suggested that
more research is needed to determine how to screen for
depressionincardiovascularpatients,andthenhowtoprovide
adequate treatment. However, the pertinent question here is:
which treatment?
In this context, a recent paper from a Finnish group
published by Honkola et al. [1] in the European Heart
Journal showed that the use of psychotropic drugs, espe-
cially the combined use of antipsychotic and antidepres-
sant drugs, was strongly associated with an increased risk
of sudden cardiac death at the time of an acute coronary
event. In a case–control study addressing a consecutive
series of 1814 victims of sudden cardiac death (mean age
65 years), the authors compared the use of psychotropic
medication between victims of sudden cardiac death and
survivors of an acute coronary event. In particular it was
shown that combined use of phenothiazines and any anti-
depressant was associated with a very high risk of sudden
cardiac death (odds ratio 18.3; p<0.001). One of the
reasons may be the pro-arrhythmic effects of psychotropic
drugs, resulting in prolonged QT intervals and torsades
des pointes.
This work coming from the University of Oulu, Finland,
may elucidate the observed phenomenon that psychiatric
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an accompanying Editorial, Josep Brugada [2]w o n d e r s
whether this is a population at higher risk for sudden cardiac
death who should be screened and treated accordingly, or is
the treatment they receive the reason for the excess mortal-
ity, and thus the drugs administered to them should be
carefully selected based on the probability of a proarrhyth-
mic effect of the therapy?
We are thus dealing with a two-edged sword. On one
hand, cardiac patients with psychiatric disorders, in particu-
lar depression, are at increased risk of coronary events; on
the other hand, psychotropic drugs administered to these
patients can be pro-arrhythmic, especially in patients prone
to myocardial ischaemia. Psychiatrists and cardiologists
should work closely together to identify the optimal medi-
cation in cardiac patients with psychiatric disorders, in par-
ticular depression [3] Amor and Psyche should support each
other, also in gloomy times [4, 5].
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